Waystar Holding Corp (WAY) stock soared 7.34% in pre-market trading on Thursday following the release of its strong first-quarter 2025 results and raised full-year guidance. The healthcare technology company reported better-than-expected earnings and revenue, demonstrating resilience in a challenging economic environment.

Waystar reported Q1 non-GAAP earnings of $0.32 per diluted share, up from $0.20 a year earlier and in line with analyst expectations. Revenue for the quarter ended March 31 came in at $256.4 million, up 14% year-over-year and surpassing the FactSet consensus estimate of $248.3 million. The company's performance was driven by robust patient payment utilization and strong subscription revenue growth of 18% year-over-year.

In response to the strong results, Waystar raised its full-year 2025 guidance. The company now expects non-GAAP EPS of $1.31 to $1.34 on revenue of $1.01 billion to $1.02 billion, up from its previous forecast in February. The raised outlook reflects confidence in Waystar's ability to capitalize on the growing demand for its AI-powered healthcare payment solutions. Following the earnings release, several analysts adjusted their price targets, with BofA Global Research raising its price objective to $49 from $48, signaling continued optimism about the company's prospects.